No Detail Found!

Effect of post-myocardial infarction streptokinase (SK) therapy, on myocardial viability -evaluation with thallium-201 single photon emission computed tomography (TL-201 spect)

Author(s)
Mohsin Saeed Shaikh Armed Forces Institute of Cardiology, Rawalpindi, Pakistan
Mehdi Raza Armed forces Institute of Cardiology, Rawalpindi, Pakistan
Zehra Naz Army medical college, Rawalpindi, Pakistan
Azhar Mahmood Kayani Armed forces Institute of Cardiology, Rawalpindi, Pakistan
Sohail Aziz Armed forces Institute of Cardiology, Rawalpindi, Pakistan
Imran Fazal Armed Forces Institute of Cardiology, Rawalpindi, Pakistan
Abstract
Objective: To evaluate the effect of post-myocardial infarction Streptokinase therapy on myocardial viability, employing Thallium-201 single photon emission computed tomography (TL-201 SPECT). Design: Retrospective, experimental study. Place and duration of study: The Nuclear Cardiology Department, Armed Forces Institute of Cardiology / National Institute of Heart Diseases, Rawalpindi, from 1st April 2009 to 31st October 2009. Patients and Methods: Male patients, who had suffered from acute myocardial infarction (AMI), in an area supplied by the left anterior descending (LAD) artery, had infarct-related electrocardiogram (ECG) changes and received or did not receive Streptokinase therapy, were included. Those with a normal ECG, or history of revascularisation, or non-ST elevation MI, or more than one MIs, were excluded. The patients were divided into groups 1 (who received Streptokinase) and 2 (who did not receive Streptokinase). Each group contained 42 patients and all underwent scintigraphic viability study through intravenous injection of 3.0 mCi (123 MBq) of TL-201, followed by rest-redistribution SPECT imaging on a dual head, dedicated cardiac gamma camera system (Philips Cardio MD ®). Emory’s cardiac toolbox ® and AutoQUANT ® were used for data processing and quantitative estimation of viable myocardium. Empirical scores from 0 to 2 were assigned to each of the scans, in the order of increasing viability, and these were compared across the two groups. Result: Group 1 contained 42 patients (age range = 38 to 80 years, mean = 53.98 ± 11.26 years), in whom empirical viability scoring was done. Score 0 was seen in 2 patients, score 1 was seen in 15 patients and score 2 was seen in 25 patients form this group. Group 2 also contained 42 patients (age range = 38 to 80 years, mean = 56.71 ± 9.05 years), in whom viability score of 0 was seen in 3 patients, score 1 was seen in 11 patients and score 2 was seen in 28 patients form this group. Age difference between the two groups was statistically insignificant (p = 0.223). The myocardial viability results analysed by 3 x 2 contingency table applying chi-square (X²) test also showed no significant difference between groups 1 and 2 (p = 0.611). Conclusion: This study did not find any significant difference in myocardial viability – post-myocardial infarction – in patients who received or did not receive Streptokinase therapy.
Publication Details
Page(s) 330-335
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 61, Issue: 3, Year: 2011

Request the full text from PASTIC

0

Citations

0

Downloads

90

Views